Immunomodulator-Mycobacterium Cell Wall Fraction as an aid in control of persistent Mycoplasma bovis infection in dairy cows

Main Article Content

Aleksandar Masic Bojana Prunic Dejan Bugarski Tamas Petrovic Jelena Apic Tomislav Barna Aleksandar Milovanovic

Abstract

Mycoplasma bovis is pathogen known to cause respiratory disease, otitis media, arthritis and a variety of additional diseases in cattle. Infections caused by this pathogen have significant impact on the health, welfare and productivity of dairy and beef cattle resulting in substantial economic losses. Current preventive and treatment strategies rely on the use of antimicrobials and vaccines; however, their efficacy is limited due to difficult diagnosis and inconsistent disease expression. Here, we report results on the use of Mycobacterium cell wall fraction (MCWF), an immunomodulator, in dairy cows persistently infected with M. bovis during the period 2011-2015. Application of MCWF aided in reducing M. bovis-associated clinical signs, such as pneumonia, arthritis and mastitis, and improving overall reproductive performance and days in lactation of infected dairy cows. These results were compared to historical information on the health status and farm performance for period 2011-2015, and suggest that MCWF immunomodulator could be introduced as an aid in treatment protocols for persistent infections with M. bovis in dairy cows.

Article Details

How to Cite
MASIC, Aleksandar et al. Immunomodulator-Mycobacterium Cell Wall Fraction as an aid in control of persistent Mycoplasma bovis infection in dairy cows. Veterinarski Glasnik, [S.l.], v. 71, n. 1, p. 58-68, may 2017. ISSN 2406-0771. Available at: <http://veterinarskiglasnik.rs/index.php/vg/article/view/VETGL170308003M>. Date accessed: 16 dec. 2017. doi: http://dx.doi.org/10.2298/VETGL170308003M.
Section
Case Reports